Bright Minds Biosciences Inc. (CSE:DRUG)
Canada · Delayed Price · Currency is CAD 116.19
+1.24 (1.08%)
May 22, 2026, 5:13 PM EST
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of CAD 1.14 billion as of May 26, 2026. Its market cap has increased by 150.80% in one year.
Market Cap
1.14B
Enterprise Value
830.45M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
116.19
Market Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from 53.34M to 1.14B, an increase of 2,037.54%. That is a compound annual growth rate of 78.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 1.14B | 32.58% |
| Dec 31, 2025 | 859.94M | 138.45% |
| Dec 31, 2024 | 360.63M | 3,710.83% |
| Dec 29, 2023 | 9.46M | -50.41% |
| Dec 30, 2022 | 19.08M | -60.52% |
| Dec 31, 2021 | 48.34M | -9.37% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 633.67M |
| Satellos Bioscience | 198.94M |
| Helix BioPharma | 124.50M |
| Quantum BioPharma | 74.56M |
| Sharp Therapeutics | 63.16M |
| Telescope Innovations | 63.03M |
| ME Therapeutics Holdings | 60.10M |
| NurExone Biologic | 58.91M |